BBNA
ALXN

Bremer Bank National Association’s Alexion Pharmaceuticals ALXN Stock Holding History

Bremer Bank National Association’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,209
Closed -$406K – 216
2021
Q2 		$406K Sell
2,209
-8,253
-79% -$1.42M 0.09% 143
2021
Q1 		$1.6M Sell
10,462
-7,127
-41% -$1.1M 0.37% 78
2020
Q4 		$2.75M Sell
17,589
-243
-1% -$31.2K 0.66% 46
2020
Q3 		$2.04M Sell
17,832
-1,092
-6% -$118K 0.54% 58
2020
Q2 		$2.12M Sell
18,924
-606
-3% -$64.3K 0.6% 49
2020
Q1 		$1.75M Buy
19,530
+230
+1% +$22.6K 0.5% 59
2019
Q4 		$2.09M Sell
19,300
-163
-0.8% -$17.4K 0.45% 66
2019
Q3 		$1.91M Sell
19,463
-84
-0.4% -$9.47K 0.42% 71
2019
Q2 		$2.56M Buy
19,547
+539
+3% +$69.5K 0.55% 49
2019
Q1 		$2.59M Buy
+19,008
New +$2.36M 0.51% 49

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Bremer Bank National Association's ALXN Position: Q3 2021 in Review

Bremer Bank National Association sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 2,209 shares — an estimated $406K sold.

Bremer Bank National Association first reported a position in ALXN in Q1 2019 and held it in 10 quarters. The position peaked at $2.75M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Bremer Bank National Association reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Bremer Bank National Association sold 2,209 Alexion Pharmaceuticals shares in Q3 2021, an estimated $406K.
  • Bremer Bank National Association first reported a position in Alexion Pharmaceuticals in Q1 2019 and held it in 10 quarters.
  • Bremer Bank National Association's Alexion Pharmaceuticals position peaked at $2.75M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Bremer Bank National Association's 13F filing for Q3 2021, filed 5 Oct 2021.